U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07329790) titled 'Indian National Study to Assess Incidence and Severity of Post-ERCP Pancreatitis After Following SOP' on Dec. 26, 2025.
Brief Summary: Endoscopic retrograde cholangiopancreatography (ERCP) is an indispensable therapeutic procedure in the management of a wide spectrum of pancreaticobiliary disorders, including choledocholithiasis, benign and malignant biliary strictures, pancreatic ductal obstructions, and postoperative bile leaks. The procedure has revolutionized the management of these conditions, often obviating the need for surgery. However, despite its therapeutic efficacy, ERCP carries a significant risk of procedure-related ad...